SyntekaBio, Inc. (KOSDAQ:226330)
South Korea · Delayed Price · Currency is KRW 1,822.00
-129.00 (-6.61%)
At close: Jun 18, 2026
SyntekaBio Revenue
SyntekaBio had revenue of 422.31M KRW in the quarter ending March 31, 2026, a decrease of -51.39%. This brings the company's revenue in the last twelve months to 2.98B, up 203.28% year-over-year. In the year 2025, SyntekaBio had annual revenue of 3.43B with 2,736.72% growth.
Revenue (ttm)
2.98B
Revenue Growth
+203.28%
P/S Ratio
14.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
44.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.43B | 3.31B | 2,736.72% |
| Dec 31, 2024 | 120.89M | -2.52M | -2.04% |
| Dec 31, 2023 | 123.41M | -120.59M | -49.42% |
| Dec 31, 2022 | 243.99M | -72.67M | -22.95% |
| Dec 31, 2021 | 316.66M | -293.02M | -48.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Osangjaiel | 136.18B |
| Daishin Information & Communications | 92.57B |
| Carelabs Co.,Ltd | 79.17B |
| ISAAC Engineering Co.,Ltd | 77.61B |
| The Asia Business Daily | 73.03B |
| NHN BUGS | 67.03B |
| Mr. Blue | 66.83B |
| iMBC Co.,Ltd. | 39.43B |